Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Bevacizumab improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

1 Nov 2007

Roche's organ-rejection drug CellCept increases risk of birth defects, miscarriage, FDA says

FDA on Monday said Roche's organ-rejection drug CellCept increases the risk of birth defects and miscarriage during the first trimester of pregnancy, Reuters reports. CellCept prevents organ rejection among kidney, liver and heart transplant recipients.

31 Oct 2007

Transplant rejection drug boosts the risk of birth defects

Authorities in the United States have issued a warning with regard to a drug used to prevent the rejection of transplanted organs.

30 Oct 2007

Most people living longer except rheumatoid arthritis sufferers

New research by the Mayo Clinic has found that while most people are living longer the same is not true for sufferers from rheumatoid arthritis.

30 Oct 2007

Comparison of mortality trends among rheumatoid arthritis subjects

An autoimmune inflammatory disease that takes a progressive toll on the heart, kidney and liver as well as the joints, rheumatoid arthritis (RA) is associated with a high risk of early death.

29 Oct 2007

New treatment option studied for bladder cancer

A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia.

29 Oct 2007

Canadian beef the culprit in E.coli outbreaks in U.S. and Canada

The Canadian Food Inspection Agency (CFIA) has issued a warning to the public regarding various beef products.

29 Oct 2007

New and safer infertility treatment produces healthy twins

The treatment known as in-vitro maturation or IVM, enables infertile couples to conceive without the need for the woman to take powerful hormonal drugs to stimulate her ovaries.

28 Oct 2007

Blood markers can help choose best dose for antiangiogenic drugs

Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth.

25 Oct 2007

Low-dose aspirin for in vitro fertilisation

Although it is inexpensive, easy to obtain and poses little health risk, women undergoing in vitro fertilization (IVF) cannot rely upon aspirin to help them become pregnant, according to a systematic review of nine studies.

23 Oct 2007

Gold-like drugs to treat arthritis

Scientists at Duke University Medical Center may have solved the mystery surrounding the healing properties of gold - a discovery they say may renew interest in gold salts as a treatment for rheumatoid arthritis and other inflammatory diseases.

22 Oct 2007

New method of oral insulin delivery patented

Syracuse University researchers have designed, tested and patented a new method of oral insulin delivery that can potentially help reduce daily insulin injections for millions of people with diabetes who require therapy for optimal glycemic control.

22 Oct 2007

Improvements in survival after dialysis in the elderly

The majority of patients starting dialysis as a result of chronic kidney disease are 65 years or older at the time of their first treatment, and many are over 75 years.

22 Oct 2007

New role discovered for cilia

Johns Hopkins researchers and colleagues have found a previously unrecognized role for tiny hair-like cell structures known as cilia: They help form our sense of touch.

22 Oct 2007

New insight into mechanisms by which E. coli colonize the intestines

Food poisoning caused by the bacteria enterohemorrhagic Eschericia coli (EHEC) O157:H7A results in severe abdominal cramps and bloody diarrhea.

19 Oct 2007

Early intervention dramatically improves outcomes for new dialysis patients

A program of education, close medical follow-up, and self-empowerment for patients with end-stage renal disease (ESRD) newly starting dialysis, reduces complications and improves outcomes - including significant reductions in mortality and hospitalization rates, reports a study in the November Clinical Journal of the American Society of Nephrology.

19 Oct 2007

Medsafe warns of "natural health" hazards

The New Zealand Ministry of Health's medicines and medical devices regulator Medsafe is warning New Zealanders to be aware of what they're buying when shopping for herbal remedies, following charges brought against a Chinese herbalist in Auckland.

19 Oct 2007

New peritoneal dialysis diagnostic discovered

Thanks to a discovery by scientists at Robarts Research Institute and The University of Western Ontario, patients undergoing peritoneal dialysis may soon be able to worry less about the risks of infection and lessen their hospital stays.

18 Oct 2007

HIV linked to increased risk of end-stage renal disease in African-Americans

For African Americans infected with HIV, the risk of end-stage renal disease (ESRD) is six times higher than for whites with HIV - and similar to the ESRD risk associated with diabetes, reports a study in the November Journal of the American Society of Nephrology.

18 Oct 2007

New mechanism discovered that mammalian cells employ to fight infections of the Hepatitis C virus

A team of researchers led by biologists at the University of California, San Diego has discovered a completely new mechanism that mammalian cells employ to fight infections of the Hepatitis C virus, which affects approximately 2.7 million Americans and 170 million people worldwide.

18 Oct 2007